High materiality9/10
Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Mizuho
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
CRBP target updated by Mizuho Securities; PT raised to $33; current price $9.76.
- Mizuho raises PT to $33; price $9.76.
Key facts
- 01
Target: $33
- 02
Posted price: $9.76
- 03
Analyst firm: Mizuho Securities
- 04
Analyst: Graig Suvannavejh
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.